phenylephrine | Nazol Baby Drops 0.125%, 10 ml p7s28754 Kids nasal spray 0.125mg / dose 10 ml

Description

Nazol Kids 10 ml - Nasal spray from the common cold for children from 4 years old nasal spray Nazrd The action of the active substance phenylephrine, which is part of the drug Nazol Advance, takes into account the features of the baby nose in the treatment of the common cold (1). Suitable for children from 4 years.

Features of this remedy are: - Thanks to phenylephrine, it helps to eliminate nasal congestion

- It acts gently (1), taking into account the peculiarities of the children's mucous membrane

- Thanks to the presence of eucalyptus in the composition it gives an additional feeling of freshness

- It facilitates breathing through the nose for colds, flu, hay fever or other allergic diseases of the upper respiratory tract, accompanied by acute rhinitis or sinusitis

1. Karpova EP, Tulupov DA On the safety and effectiveness of nasal sucking osuzhivayuschih drugs in pediatric practice. // Questions of practical pediatrics, 2010, v. 5, No. 5, p. 6569. Phenylephrine has selective agonism for 1-adrenergic receptors, It has a mild vasoconstrictor effect, presumably due to the predominant effect on the obturator choke vessels (superficial arterioles, nasal mucosa), and does not significantly reduce blood flow in it.

Release form

A clear, colorless to light yellow solution with a faint eucalyptus odor.

Packaging

15 ml - plastic bottles (1) with a spray - packs of cardboard. 30 ml - plastic bottles (1) with a spray - packs of cardboard.

Pharmacological action

Decongestant - -adrenomimetic

Code ATC: R01AA04

Pharmacological properties of

A drug for symptomatic topical treatment of rhinitis. Phenylephrine hydrochloride is an alpha-1-adrenergic receptor agonist (sympathomimetic), which has a vasoconstrictor effect by stimulating alpha-1-receptors in the nasal mucous membranes, reduces swelling of the mucous membranes and tissue hyperemia, congestion in the nasal mucosa, and also improves patency nasal airways. Restoring the airway of the nasopharynx improves the patient’s well-being and reduces the risk of possible complications caused by stagnation of the mucous secretion.

Pharmacokinetics

When applied topically, systemic absorption is low.

Indications

Symptomatic treatment: to facilitate breathing through the nose for colds, flu, hay fever or other allergic diseases of the upper respiratory tract, accompanied by acute rhinitis or sinusitis.

Contraindications

Increased individual sensitivity to the ingredients of the drug,

diseases of the cardiovascular system (including severe atherosclerosis, angina pectoris, tachycardia)

thyroid disease (thyrotoxicosis)

diabetes mellitus

arterial hypertension

simultaneous administration of MAO inhibitors (as well as 2 weeks after their withdrawal)

children under 4 years of age.

Caution with children (6 years old).

Use during pregnancy and lactation

There is no sufficient experience with the use of the drug during pregnancy.

The use of the drug during pregnancy and lactation (breastfeeding) is only possible if the intended benefit to the mother outweighs the potential risk to the fetus or child.

Composition

100 ml contains:

active ingredient:

phenylephrine hydrochloride 0.25 g

excipients:

benzalkonium chloride 0.018 g,

eucalyptol (cineol) 0.040 g, srdlk 1,500, srdlp 1,500 gr,

1,500 g, srdlpp 1,500 g,

1,500 g,

1,500 g hydrogen phosphate dihydrate 0.226 g,

potassium dihydrogen phosphate 0.101 g,

disodium edetate dihydrate 0.020 g,

purified water 95.845 g

Side effects

Local reactions: burning, tingling, or tingling sensations in the nose.

Systemic effects: headache, dizziness, palpitations, arrhythmia, increased blood pressure, sweating, pallor, tremor, sleep disturbance.

Drug interactions

Monoamine oxidase inhibitors (procarbazine, selegiline), tricyclic antidepressants, maprotiline, guanedrel, guanethidine enhance the pressor effect and phenylephrine arrhythmogenicity (with systemic absorption).

Thyroid hormones with systemic absorption of phenylephrine increase the (mutually) associated risk of coronary insufficiency (especially with coronary atherosclerosis).

Overdose

May occur with heart rhythm disorders, increase in blood pressure, excitation.

Consult your doctor for overdose.

Treatment is symptomatic.

Storage Conditions

In a dark place at a temperature not exceeding 25 РC.

Shelf life

2 years

Terms and conditions

without prescription

dosage form

nasal spray

Appointment

Appointment

Children form